The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
merck & company | 15070 |
schering corporation | 2495 |
organon | 515 |
sirna therapeutics | 352 |
banyu pharmaceutical company | 325 |
merck canada | 241 |
cubist pharmaceuticals | 180 |
merck frosst canada & company | 178 |
istituto di ricerche di biologia m… 🛈 | 178 |
msd oss | 162 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
rna interference mediated inhibition of gene expression using chemically modified short … 🛈 | 171 | 2002 |
binding-site modified lectins and uses thereof | 106 | 2009 |
iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use | 69 | 2009 |
piperidinone carboxamide azaindane cgrp receptor antagonists | 68 | 2010 |
aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevent… 🛈 | 65 | 2008 |
macrocyclic quinoxaline compounds as hcv ns3 protease inhibitors | 63 | 2008 |
hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists | 60 | 2008 |
5-phenoxy-3h-pyrimidin-4-one derivatives and their use as hiv reverse transcriptase inhi… 🛈 | 58 | 2012 |
beta-lactamase inhibitors | 56 | 2008 |
inhibitors of hepatitis c virus replication | 55 | 2009 |